Poulome Mukherjee
Poulome Mukherjee has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Ravi Kannan
Cachar Cancer Hospital and Research Centre
2 shared publications - Aleksandra Gentry-Maharaj
Department of Women’s Cancer, Institute for Women’s Health, University College London, London, UK
1 shared publication - Antonis C. Antoniou
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge , Cambridge CB1 8RN
1 shared publication - Anupama Rajanbabu
The James Cook Cancer Institute, James Cook University Hospital, England, United Kingdom
1 shared publication - Aparajita Bhasin
Quicksand Design Studio, New Delhi 110047, India
1 shared publication - Ashutosh Mishra
Department of Surgical Oncology Dr. B. R. Ambedkar Institute Rotary Cancer Hospital (IRCH) All India Institute of Medical Sciences New Delhi India
1 shared publication
Latest Publications
- Open Access
- 10 November 2025
- Published by Springer Nature in Research Square
PUM1 and RPN1 are Optimum Reference Genes for Differential Gene Expression Analysis of Cancer Stem Cell and Epithelial-to-Mesenchymal Transition Markers in Breast Cancer
Background: Reliability of differential gene expression analysis in cancer studies depends on the selection of normalising reference genes. The current study aimed to identify and validate suitable reference genes for the normalization of quantitative real-time polymerase chain reaction (qPCR)-based differential gene expression analysis of cancer stem cells (CSC) and epithelial-to-mesenchymal transition (EMT) markers in breast cancer tissue. Methodology: The expression stability of six candidate reference genes— PUM1, RPN1, GUSB, PMM1, GAPDH, and B2M —across 18 breast cancer specimens was assessed using qPCR method. Gene stability was analysed using RefFinder algorithm. Further, the suitability of the optimum reference genes was assessed using qPCR-based differential gene expression analysis of CSC and EMT markers, namely ALDH1 , VIM , TWIST , and CDH1 , in a cohort of breast cancer tissues constituting the four intrinsic molecular subgroups– Luminal A, Luminal B, Triple Negative Breast Cancer (TNBC), and HER 2-Enriched. Results: The geometric mean of C q values for PUM1, RPN1, GUSB, PMM, B2M, and GAPDH were found 19.95, 18.26, 21.12, 22.10, 14.64, and 16.0, respectively. ReFfinder provided a comprehensive assessment of gene stability, ranking the candidate reference genes in the following order of decreasing stability: PUM1 (1.0), RPN1 (1.86), GUSB (3.41), PMM (4.0), B2M (4.56), and GAPDH (5.23). PUM1 and RPN1 were observed as the most stably expressed reference genes whereas GAPDH was most unstably expressed across all the breast cancer tissues. Using PUM1 and RPN1 as reference genes, the following gene expression patterns were observed: ALDH1 showed the lowest expression in Luminal B; TWIST and VIM expressions peaked in HER 2-Enriched subtype, with VIM being expressed the lowest in Luminal B; CDH1 expression was lowest in HER 2-Enriched and highest in Luminal B. Conclusion: In our cohort PUM1 and RPN1 reference genes were found to be most stable and were suitable for the normalization of qPCR-based gene expression of CSC and EMT markers. However, these findings need to be validated on a larger cohort.
- 10 November 2025
- Published by Springer Nature in Research Square
Open AccessPUM1 and RPN1 are Optimum Reference Genes for Differential Gene Expression Analysis of Cancer Stem Cell and Epithelial-to-Mesenchymal Transition Markers in Breast Cancer
Background: Reliability of differential gene expression analysis in cancer studies depends on the selection of normalising reference genes. The current study aimed to identify and validate suitable reference genes for the normalization of quantitative real-time polymerase chain reaction (qPCR)-based differential gene expression analysis of cancer stem cells (CSC) and epithelial-to-mesenchymal transition (EMT) markers in breast cancer tissue. Methodology: The expression stability of six candidate reference genes— PUM1, RPN1, GUSB, PMM1, GAPDH, and B2M —across 18 breast cancer specimens was assessed using qPCR method. Gene stability was analysed using RefFinder algorithm. Further, the suitability of the optimum reference genes was assessed using qPCR-based differential gene expression analysis of CSC and EMT markers, namely ALDH1 , VIM , TWIST , and CDH1 , in a cohort of breast cancer tissues constituting the four intrinsic molecular subgroups– Luminal A, Luminal B, Triple Negative Breast Cancer (TNBC), and HER 2-Enriched. Results: The geometric mean of C q values for PUM1, RPN1, GUSB, PMM, B2M, and GAPDH were found 19.95, 18.26, 21.12, 22.10, 14.64, and 16.0, respectively. ReFfinder provided a comprehensive assessment of gene stability, ranking the candidate reference genes in the following order of decreasing stability: PUM1 (1.0), RPN1 (1.86), GUSB (3.41), PMM (4.0), B2M (4.56), and GAPDH (5.23). PUM1 and RPN1 were observed as the most stably expressed reference genes whereas GAPDH was most unstably expressed across all the breast cancer tissues. Using PUM1 and RPN1 as reference genes, the following gene expression patterns were observed: ALDH1 showed the lowest expression in Luminal B; TWIST and VIM expressions peaked in HER 2-Enriched subtype, with VIM being expressed the lowest in Luminal B; CDH1 expression was lowest in HER 2-Enriched and highest in Luminal B. Conclusion: In our cohort PUM1 and RPN1 reference genes were found to be most stable and were suitable for the normalization of qPCR-based gene expression of CSC and EMT markers. However, these findings need to be validated on a larger cohort.
- Open Access
Co-Creation of Breast Cancer Risk Communication Tools and an Assessment of Risk Factor Awareness: A Qualitative Study of Patients and the Public in India
Background: Low awareness of BC and its associated risk factors causes delays in diagnosis and impacts survival. It is critical to communicate BC risk to patients in a format that they are easily able to understand. Our study aim was to develop easy-to-follow transmedia prototypes to communicate BC risk and evaluate user preferences, alongside exploring awareness of BC and its risk factors. Methods: Prototypes of transmedia tools for risk communication were developed with multidisciplinary input. A qualitative in-depth online interview study was undertaken using a pre-defined topic guide of BC patients (7), their relatives (6), the general public (6), and health professionals (6). Interviews were analyzed using a thematic approach. Findings: Most participants preferred pictographic representations (frequency format) of lifetime risk and risk factors and storytelling using short animations and comic strips (infographics) for communicating genetic risk and testing: “In a short time, they explained it very well, and I liked it”. Suggestions included minimizing technical terminology, decreasing the delivery speed, “two-way dialogue”, and using local “language for different locations”. There was low awareness of BC, with some understanding of age and hereditary risk factors but limited knowledge of reproductive factors. Interpretation: Our findings support use of multiple context-specific multimedia tools in communicating cancer risk in an easy-to-understand way. The preference for storytelling using animations and infographics is a novel finding and should be more widely explored.
Open AccessCo-Creation of Breast Cancer Risk Communication Tools and an Assessment of Risk Factor Awareness: A Qualitative Study of Patients and the Public in India
Background: Low awareness of BC and its associated risk factors causes delays in diagnosis and impacts survival. It is critical to communicate BC risk to patients in a format that they are easily able to understand. Our study aim was to develop easy-to-follow transmedia prototypes to communicate BC risk and evaluate user preferences, alongside exploring awareness of BC and its risk factors. Methods: Prototypes of transmedia tools for risk communication were developed with multidisciplinary input. A qualitative in-depth online interview study was undertaken using a pre-defined topic guide of BC patients (7), their relatives (6), the general public (6), and health professionals (6). Interviews were analyzed using a thematic approach. Findings: Most participants preferred pictographic representations (frequency format) of lifetime risk and risk factors and storytelling using short animations and comic strips (infographics) for communicating genetic risk and testing: “In a short time, they explained it very well, and I liked it”. Suggestions included minimizing technical terminology, decreasing the delivery speed, “two-way dialogue”, and using local “language for different locations”. There was low awareness of BC, with some understanding of age and hereditary risk factors but limited knowledge of reproductive factors. Interpretation: Our findings support use of multiple context-specific multimedia tools in communicating cancer risk in an easy-to-understand way. The preference for storytelling using animations and infographics is a novel finding and should be more widely explored.